Anesthesia

The Rise Fund Acquires Blue Cloud Pediatric Surgery Centers

Retrieved on: 
Monday, February 28, 2022

The Rise Fund, TPGs multi-sector global impact investing strategy, today announced the acquisition of Blue Cloud Pediatric Surgery Centers (Blue Cloud), the largest operator of pediatric dental ambulatory surgery centers (ASCs) in the U.S.

Key Points: 
  • The Rise Fund, TPGs multi-sector global impact investing strategy, today announced the acquisition of Blue Cloud Pediatric Surgery Centers (Blue Cloud), the largest operator of pediatric dental ambulatory surgery centers (ASCs) in the U.S.
  • For pediatric patients requiring general anesthesia due to case severity, Blue Cloud provides a lower cost alternative to hospitals, while expanding access to care and maintaining the highest levels of quality and medical compliance.
  • Blue Cloud joins a number of other healthcare investments in the Rise portfolio that are working towards achieving this specific goal.
  • Blue Cloud Pediatric Surgery Centers is the largest operator of pediatric dental ambulatory surgery centers (ASCs) in the US with 15 facilities across 6 states serving over 23,000 patients per year.

Nurse Anesthetists Highlight the Impact of Racism and Nursing

Retrieved on: 
Thursday, February 24, 2022

PARK RIDGE, Ill., Feb. 24, 2022 /PRNewswire/ -- A national survey revealed racism remains a challenge across the nursing profession.

Key Points: 
  • PARK RIDGE, Ill., Feb. 24, 2022 /PRNewswire/ -- A national survey revealed racism remains a challenge across the nursing profession.
  • Both work groups are part of the American Nurses Association (ANA) National Commission to Address Racism in Nursing .
  • "It is important for the AANA and Certified Registered Nurse Anesthetists (CRNAs) to be involved in the work of the Commission because ethnic minorities have historically been underrepresented in the profession of nurse anesthesia, "said Dr. Rose.
  • In addition, understanding racism in nursing and healthcare overall could positively impact research: increasing diversity among researchers, bringing more funds to diseases that predominantly impact people of color, as well as validating research findings for all people."

Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022

Retrieved on: 
Thursday, February 24, 2022

MIAMI BEACH, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that its wholly owned subsidiary, Pasithea Clinics, has expanded its treatment offerings and is planning to open three new clinics in London to treat patients suffering from mental health issues. The Company already has locations in Marylebone and Knightsbridge.

Key Points: 
  • In addition to pharmacy services, our London clinics will offer other psychiatric treatment therapies, including repeated transcranial magnetic stimulation and ketamine and esketamine treatment, stated Dr. Tiago Reis Marques, CEO of Pasithea Therapeutics.
  • We are excited to expand our partnership with ZEN Healthcare, which has been providing pioneering IV therapies in London for six years.
  • The clinics, which will be operated by Pasithea, with management support from ZEN Healthcare, are expected to open by mid-2022.
  • Pasithea Therapeutics Corporation is a U.S. biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

Teleflex Announces Quarterly Dividend

Retrieved on: 
Thursday, February 24, 2022

WAYNE, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.

Key Points: 
  • WAYNE, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.
  • The dividend is payable March 15, 2022, to shareholders of record at the close of business on March 7, 2022.
  • Additional information about Teleflex can be obtained from the companys website at teleflex.com .
  • Teleflex is a global provider of medical technologies designed to improve the health and quality of peoples lives.

Global Lithotripsy Devices Industry Worth $1.78B by 2026 - Discover the Leading Products, Services, Developments, and Competitors - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 23, 2022

Owing to the occurrence of stones in various parts of the body, the Lithotripsy Devices market will rise significantly.

Key Points: 
  • Owing to the occurrence of stones in various parts of the body, the Lithotripsy Devices market will rise significantly.
  • Thus, the burgeoning cases of urolithiasis will contribute to the Global Lithotripsy Devices Market growth.
  • Such technological advancement in the field of Lithotripsy Devices is likely to boost the Global Lithotripsy Devices Market during the forecast period.
  • In the by-type segment of the Lithotripsy Devices market, the Extracorporeal Shock Wave Lithotripsy Devices (ESWL) market segment will hold a significant share in the Global Lithotripsy Devices market.

Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures

Retrieved on: 
Wednesday, February 23, 2022

Given the challenging patient population, the high technical success rate in this most demanding PCI environment is particularly notable.

Key Points: 
  • Given the challenging patient population, the high technical success rate in this most demanding PCI environment is particularly notable.
  • The CTO-PCI IDE study confirmed the safety and effectiveness of a range of these products in very complex CTO cases, said Teleflex Medical Director, Dr. Christopher Buller.
  • Interventional cardiologists who have evolved the techniques for these difficult procedures need innovative, enabling devices they can absolutely count on, he said.
  • Impact of Chronic Total Occlusion of the Coronary Artery on Long-Term Prognosis in Patients With Ischemic Systolic Heart Failure: Insights From the COMMIT-HF Registry.

Insights on the Breast Implant Global Market to 2027 - by Product, Shape, Application, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 22, 2022

Breast implants surgery includes anesthesia, incision, insertion, placement, and closing of the devices with layered sutures or surgical tape in the breast tissue.

Key Points: 
  • Breast implants surgery includes anesthesia, incision, insertion, placement, and closing of the devices with layered sutures or surgical tape in the breast tissue.
  • At present, the breast implant is commercially available in varying types, such as saline, silicone, structured, gummy bear, round, textured and smooth breast implants.
  • Key Questions Answered in this Report:
    How has the global breast implant market performed so far and how will it perform in the coming years?
  • What is the structure of the global breast implant market and who are the key players?

MASS GENERAL HOSPITAL TO PAY $14.6 MILLION TO RESOLVE OVERLAPPING SURGERY CLAIMS; STANDARDIZED CONSENT FORMS TO BE AMENDED

Retrieved on: 
Saturday, February 19, 2022

MGH will pay $14.6 million to the federal government and Massachusetts and change its informed consent language to better apprise patients of when their surgeon has an overlapping surgical obligation.

Key Points: 
  • MGH will pay $14.6 million to the federal government and Massachusetts and change its informed consent language to better apprise patients of when their surgeon has an overlapping surgical obligation.
  • These statutes allow individuals, under certain circumstances, to bring suit in the name of the government to return money to the government treasury.
  • I understand that my surgeon or another qualified surgeon will be immediately available should the need arise during my surgery.
  • Since the court's precedential ruling, overlapping surgery cases have been brought and resolved in New York and Arizona.

Xoran Reaches 1000 Installations Worldwide

Retrieved on: 
Friday, February 18, 2022

ANN ARBOR, Mich., Feb. 18, 2022 /PRNewswire/ -- "Fast on the heels of Xoran's announcement of 900 MiniCAT™ and 50 VetCAT™ installations, we are proud to announce that Xoran has reached 1,000 system installations worldwide," says Misha Rakic, CEO of Xoran Technologies.

Key Points: 
  • ANN ARBOR, Mich., Feb. 18, 2022 /PRNewswire/ --"Fast on the heels of Xoran's announcement of 900 MiniCAT and 50 VetCAT installations, we are proud to announce that Xoran has reached 1,000 system installations worldwide," says Misha Rakic, CEO of Xoran Technologies.
  • As the pioneer and medical market leader in point-of-care cone beam CT since 2001, Xoran's team of domestic sales and customer service, along with international distributors, reaches 1,000 global device installs.
  • Xoran specifically designed its xCAT suite of products for use in the operating room and critical care unit.
  • With this progression, Xoran is working to demonstrate the potential of integrating surgical navigation capability into a mobile CT device.

The Worldwide Anesthetic Drugs is Expected to Reach $6.4 Billion by 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 18, 2022

The Global Anesthetic Drugs Market is estimated to be USD 4.68 Bn in 2021 and is expected to reach USD 6.42 Bn by 2026, growing at a CAGR of 6.52%.

Key Points: 
  • The Global Anesthetic Drugs Market is estimated to be USD 4.68 Bn in 2021 and is expected to reach USD 6.42 Bn by 2026, growing at a CAGR of 6.52%.
  • The major factors driving the growth of the global anesthetic drugs market are the growing number of operations such as cardiac, orthopedic, general surgeries, and pain management.
  • The Global Anesthetic Drugs Market is segmented based on Drug Type, Route of Administration, Application, and Geography.
  • The report offers a comprehensive evaluation of the Global Anesthetic Drugs Market.